Suchergebnisse - "Evans, Joanne S"

PubPharm (13)

1

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer : results from the OnCovid registry

enthalten in: The Lancet. Oncology | 2023

von Cortellini, A. | Tabernero, J. | Mukherjee, U. | +126

2

Epigenetic potentiation of somatostatin-2 by guadecitabine in neuroendocrine neoplasias as a novel method to allow delivery of peptide receptor radiotherapy

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Evans, J. | Beaumont, J. | Braga, M. | +9

3

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Pinato, D. | Ferrante, D. | Aguilar-Company, J. | +149

4

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe : results from the retrospective, multicentre, OnCovid registry study

enthalten in: The Lancet. Oncology | 2022

von Pinato, D. | Aguilar-Company, J. | Ferrante, D. | +147

5

Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations

enthalten in: Journal for immunotherapy of cancer | 2022

von Cortellini, A. | Ricciuti, B. | Vaz, V. | +32

6

Time-Dependent COVID-19 Mortality in Patients With Cancer : An Updated Analysis of the OnCovid Registry

enthalten in: JAMA oncology | 2022

von OnCovid Study Group | Pinato, D. | Patel, M. | +78

7

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection : evidence from the OnCovid retrospective, multicentre registry study

enthalten in: The Lancet. Oncology | 2021

von Pinato, D. | Tabernero, J. | Bower, M. | +130

8

Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer : a European study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Pinato, D. | Scotti, L. | Gennari, A. | +67

CommentIn: Lancet Oncol. 2021 Jun;22(6):755. - PMID 33894836

9

Programmed Cell Death Ligand Expression Drives Immune Tolerogenesis across the Diverse Subtypes of Neuroendocrine Tumours

enthalten in: Neuroendocrinology | 2021

von Pinato, D. | Vallipuram, A. | Evans, J. | +9

10

Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients

enthalten in: Cancer discovery | 2020

von Pinato, D. | Zambelli, A. | Aguilar-Company, J. | +61